|
Report Date : |
23.11.2012 |
IDENTIFICATION DETAILS
|
Name : |
BRUKER AXS HANDHELD INC. |
|
|
|
|
|
|
Registered Office : |
|
|
|
|
|
|
|
Country : |
United State |
|
|
|
|
|
|
Date of Incorporation : |
28.12.2000 |
|
|
|
|
|
|
Legal Form : |
Corporation – Profit |
|
|
|
|
|
|
Line of Business : |
Develops and manufactures of portable X-ray fluorescence systems for
various applications. |
|
|
|
|
|
|
No. of Employees : |
45 |
|
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
-- |
NB |
New Business |
-- |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2011) |
Current Rating (30.06.2012) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
United States - ECONOMIC OVERVIEW
The
|
Source : CIA |
Company name: BRUKER
AXS HANDHELD INC.
Address:
Telephone: +1
509-783-9850
Fax: +1 509-735-9696
Website: www.bruker.com
Corporate ID#: 3337351
State:
Judicial form: Corporation – Profit
Date incorporated: 12-28-2000
Stock: -
Value: -
Name of manager: John
LANDEFELD
Business:
BRUKER AXS HANDHELD develops and manufactures portable X-ray
fluorescence systems for various applications.
The company provides positive material identification systems for the
aerospace and power industries. It offers metals and alloy analysis services for
the metal processing industry. KeyMaster Technologies provides products for
art, museum and archaeological analysis.
Bruker AXS designs analytical X-ray systems for elemental analysis,
materials research and structural investigations. It serves clients in the
chemistry, pharmacy, semiconductor, life science and nanotechnology industries.
The company sells spectrometers for laboratory and on-site analysis.
Bruker AXS offers X-ray diffraction solutions and metal analyzers.
It offers X-ray tubes, detectors and optics.
The company has received ISO 9001:2000 certification from the
International Organization for Standardization.
No name of suppliers available.
The Company exports to Central and
EIN: 91-2120223
Staff: 45
Operations & branches:
At the headquarters, we
find a factory, warehouse and office, owned.
Shareholders:
BRUXER AXS INC. 100%
Bruker AXS, Inc. designs, develops, and manufactures analytical X-ray
systems for elemental analysis, materials research, and structural
investigations.
It offers X-ray and handheld X-ray spectrometry solutions, optical
emission spectrometers, wavelength and energy dispersive X-ray spectrometry
systems, X-ray diffraction solutions, X-ray metrology analytics, and combustion
analysis. The company also provides atomic force and scanning probe
microscopes, biological and chemical crystallography solutions, radionuclide
analysis equipment, lab and process automation instruments, and X-ray
components. Its solutions are used in various applications, including aluminum
and metallurgy, art and conservation, cement and raw materials, ceramics and
refractories, environment and waste management, forensics, glass and coatings,
life sciences, metals and automotive, new materials and nano-materials, oils
and lubricants, liquids and amorphous samples, pharmaceuticals, plastics and
polymers, refinery, semiconductors, and restriction of hazardous substances, as
well as minerals, mining, and geology applications. The company was
incorporated in 1997 and is based in
The ultimate parent company is:
BRUKER CORP.
Bruker Corporation designs, manufactures, services, and sells
proprietary life science and materials research systems worldwide.
The company’s Scientific Instruments segment offers advanced instrumentation
and automated solutions based on magnetic resonance, mass spectrometry, gas
chromatography, X-ray, spark-optical emission spectroscopy, atomic force
microscopy, stylus and optical metrology, and infrared and Raman molecular
spectroscopy technologies. This segment serves pharmaceutical, biotechnology,
and molecular diagnostic companies; academic institutions, medical schools, and
other non-profit organizations; clinical microbiology laboratories; government
departments and agencies; nanotechnology, semiconductor, chemical, cement,
metals, and petroleum companies; and food, beverage, and agricultural analysis
companies and laboratories. Its Energy & Supercon Technologies segment
provides superconducting materials, including metallic low temperature
superconductors for use in magnetic resonance imaging, nuclear magnetic
resonance, fusion energy research, and other applications; and ceramic high
temperature superconductors primarily for fusion energy research applications,
as well as non-superconducting Cuponal materials and wires based on co-extruded
copper and aluminum, and non-superconducting high technology tools. Its
customers include companies in the medical industry; private and public
research and development laboratories in the fields of fundamental and applied
sciences, and energy research; academic institutions; and government agencies.
This segment is also involved in the development of superconductors and
superconducting-enabled devices for applications in power and energy, as well
as industrial processing industries.
The company markets its products through direct sales force; and
distributors, independent sales representatives, and other representatives.
Bruker Corporation was founded in 1991 and is headquartered in
The Company is listed with the Nasdaq under symbol BRKR.
Management:

John LANDEFELD is the President and CEO
He is present with the Company since January 2001
Graduate from
Frank LAUKIEN, Chairman of the group.
Dr. Frank H. Laukien, Ph.D. has been the Chairman, Chief Executive
Officer and President of Bruker Corporation (Alternate Name Bruker BioSciences
Corp.) at Bruker BioSpin GmbH and Bruker Optics Inc. since February 1991.
Dr. Laukien has been the Chairman of the Board, President and Chief
Executive Officer of Bruker Daltonics Inc. since February 1991. Dr. Laukien
serves as Chief Executive Officer and President of Bruker BioSciences.
Dr. Laukien has been the President of Bruker BioSpin Corporation, an
affiliate of Bruker BioSciences, since June 1997 and serves as its Co-Chief
Executive Officer. He has been the Co-Chief Executive Officer of the worldwide
Bruker BioSpin family of companies since December 2002.
Dr. Laukien served as the Chief Executive Officer of Bruker AXS Inc.
from October 1997 to March 2000 and its Executive Chairman from October 1997 to
July 2003. Dr. Laukien has been a Director of Bruker BioSciences Corp. since
June 1997. He has been Director of Bruker Energy & Supercon Technologies,
Inc. since April 2008. He has been Director of Bruker BioSpin Corporation since
June 1997. He served as a Director at Bruker AXS Inc. from October 1997 to
March 2000. A part-time professor of mass spectrometry at the
In November 2001, he was elected an officer and Chairman-Elect of ALSSA
(Analytical & Life Science Systems Association), an industry organization.
Lisa ROGERS, Treasurer
Richard STEIN, Secretary
Subsidiaries
And partnership: None
In
On a direct call, a
financial assistant controlled the present report and confirmed that all financials
are consolidated into the parent company, which reported sales for year 2011 up
to USD 1,640,400,000= and a net profit of USD 92,300,000=
Estimate revenue for the
Company in 2011 is in the range of USD 15,000,000=
Banks: Bank of
Legal filings
& complaints:
As of today date, there is no legal filing pending with the Courts.
Secured debts summary (UCC):
None